138 related articles for article (PubMed ID: 33066406)
21. The role of CD98 heavy chain in cancer development.
Park E; Kim H; Yoon S; Jang B
Histol Histopathol; 2024 Apr; ():18749. PubMed ID: 38695393
[TBL] [Abstract][Full Text] [Related]
22. The role of L-type amino acid transporter 1 in human tumors.
Zhao Y; Wang L; Pan J
Intractable Rare Dis Res; 2015 Nov; 4(4):165-9. PubMed ID: 26668776
[TBL] [Abstract][Full Text] [Related]
23. A rapid and simple non-radioactive assay for measuring uptake by solute carrier transporters.
Song K; Zhang L; Fu X; Li L; Zhu G; Wu M; Zhang W; He J; Zhu S; Dang Y; Liu JY; Chen C; Guo Z
Front Pharmacol; 2024; 15():1355507. PubMed ID: 38720778
[No Abstract] [Full Text] [Related]
24. Cryo-EM structure of the human Asc-1 transporter complex.
Li Y; Guo Y; Bröer A; Dai L; Brӧer S; Yan R
Nat Commun; 2024 Apr; 15(1):3036. PubMed ID: 38589439
[TBL] [Abstract][Full Text] [Related]
25. Structure and mechanisms of transport of human Asc1/CD98hc amino acid transporter.
Rullo-Tubau J; Martinez-Molledo M; Bartoccioni P; Puch-Giner I; Arias Á; Saen-Oon S; Stephan-Otto Attolini C; Artuch R; Díaz L; Guallar V; Errasti-Murugarren E; Palacín M; Llorca O
Nat Commun; 2024 Apr; 15(1):2986. PubMed ID: 38582862
[TBL] [Abstract][Full Text] [Related]
26. Rush Hour of LATs towards Their Transport Cycle.
Nicolàs-Aragó A; Fort J; Palacín M; Errasti-Murugarren E
Membranes (Basel); 2021 Aug; 11(8):. PubMed ID: 34436365
[TBL] [Abstract][Full Text] [Related]
27. Transporter Protein Expression of Corneal Epithelium in Rabbit and Porcine: Evaluation of Models for Ocular Drug Transport Study.
Ramsay E; Montaser AB; Niitsu K; Urtti A; Auriola S; Huttunen KM; Uchida Y; Kidron H; Terasaki T
Mol Pharm; 2024 May; ():. PubMed ID: 38809137
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive Characterization of LAT1 Cholesterol-Binding Sites.
Hutchinson K; Schlessinger A
J Chem Theory Comput; 2024 Apr; 20(8):3349-3358. PubMed ID: 38597304
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive review of amino acid transporters as therapeutic targets.
Xia R; Peng HF; Zhang X; Zhang HS
Int J Biol Macromol; 2024 Mar; 260(Pt 2):129646. PubMed ID: 38272411
[TBL] [Abstract][Full Text] [Related]
30. Mammalian Atg8-family proteins are upstream regulators of the lysosomalsystem by controlling MTOR and TFEB.
Kumar S; Jain A; Choi SW; Peixoto Duarte da Silva G; Allers L; Mudd MH; Peters RS; Anonsen JH; Rusten TE; Lazarou M; Deretic V
Autophagy; 2020 Dec; 16(12):2305-2306. PubMed ID: 33070669
[TBL] [Abstract][Full Text] [Related]
31. Structural insight into the substrate recognition and transport mechanism of the human LAT2-4F2hc complex.
Yan R; Zhou J; Li Y; Lei J; Zhou Q
Cell Discov; 2020 Nov; 6(1):82. PubMed ID: 33298890
[No Abstract] [Full Text] [Related]
32. Mechanism of substrate transport and inhibition of the human LAT1-4F2hc amino acid transporter.
Yan R; Li Y; Müller J; Zhang Y; Singer S; Xia L; Zhong X; Gertsch J; Altmann KH; Zhou Q
Cell Discov; 2021 Mar; 7(1):16. PubMed ID: 33758168
[TBL] [Abstract][Full Text] [Related]
33. Association of High LAT1 Expression with Poor Prognosis and Recurrence in Colorectal Cancer Patients Treated with Oxaliplatin-Based Adjuvant Chemotherapy.
Shibasaki Y; Yokobori T; Sohda M; Shioi I; Ozawa N; Komine C; Suga K; Nakazawa N; Osone K; Shiraishi T; Okada T; Sano A; Sakai M; Ogawa H; Kaira K; Shirabe K; Saeki H
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768934
[TBL] [Abstract][Full Text] [Related]
34. The human LAT1-4F2hc (SLC7A5-SLC3A2) transporter complex: Physiological and pathophysiological implications.
Kahlhofer J; Teis D
Basic Clin Pharmacol Toxicol; 2023 Nov; 133(5):459-472. PubMed ID: 36460306
[TBL] [Abstract][Full Text] [Related]
35. N-glycosylation is crucial for trafficking and stability of SLC3A2 (CD98).
Console L; Scalise M; Salerno S; Scanga R; Giudice D; De Bartolo L; Tonazzi A; Indiveri C
Sci Rep; 2022 Aug; 12(1):14570. PubMed ID: 36028562
[TBL] [Abstract][Full Text] [Related]
36. Structural basis for substrate specificity of heteromeric transporters of neutral amino acids.
Rodriguez CF; Escudero-Bravo P; Díaz L; Bartoccioni P; García-Martín C; Gilabert JG; Boskovic J; Guallar V; Errasti-Murugarren E; Llorca O; Palacín M
Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34848541
[TBL] [Abstract][Full Text] [Related]
37. Analysis of L-leucine amino acid transporter species activity and gene expression by human blood brain barrier hCMEC/D3 model reveal potential LAT1, LAT4, B
Taslimifar M; Faltys M; Kurtcuoglu V; Verrey F; Makrides V
J Cereb Blood Flow Metab; 2022 Jan; 42(1):90-103. PubMed ID: 34427144
[TBL] [Abstract][Full Text] [Related]
38. Yeast Cell-Based Transport Assay for the Functional Characterization of Human 4F2hc-LAT1 and -LAT2, and LAT1 and LAT2 Substrates and Inhibitors.
Kantipudi S; Fotiadis D
Front Mol Biosci; 2021; 8():676854. PubMed ID: 34124158
[TBL] [Abstract][Full Text] [Related]
39. The complete assembly of human LAT1-4F2hc complex provides insights into its regulation, function and localisation.
Wu D; Yan R; Song S; Swansiger AK; Li Y; Prell JS; Zhou Q; Robinson CV
Nat Commun; 2024 May; 15(1):3711. PubMed ID: 38697966
[TBL] [Abstract][Full Text] [Related]
40. LAT1 (SLC7A5) catalyzes copper(histidinate) transport switching from antiport to uniport mechanism.
Scanga R; Scalise M; Marino N; Parisi F; Barca D; Galluccio M; Brunocilla C; Console L; Indiveri C
iScience; 2023 Oct; 26(10):107738. PubMed ID: 37692288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
